China Jo-Jo Drugstores hosts first suppliers conference in China

China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the Company hosted its first suppliers conference (the "Conference") in Haiwaihai International Conference Center of Hangzhou, China at the end of December 2020, which was attended by approximately 200 representatives of its suppliers. To fulfill its vision to make the world healthier, Jo-Jo Drugstores endeavors to work with its suppliers to ensure that all of its products and services meet the highest standards of integrity, affordability and sustainability.

During the conference, the Company entered into certain strategic cooperation framework agreements (the "Agreements") with 11 prestigious companies including Direct-to-Patient (DtP) Medicine Branch of Huadong Pharmaceutical Co., Ltd., Pfizer Inc., Hangzhou MSD Pharmaceutical Co., Ltd., Sanofi (Hangzhou) Pharmaceuticals Co., Ltd., AstraZeneca plc., China Medical System Holdings Ltd., Beijing Novartis Pharma Co., Ltd. and Wyeth, LLC.

Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "The conference allowed Jo-Jo Drugstores to talk directly with 200 suppliers about the Company's outlook, our commitment to ethics and business conduct, and our supply chain initiatives. The retail industry of China's pharmaceutical and other healthcare products is entering into an era of fast development filled with tremendous challenges and opportunities brought by the current complicated economics situation. The Company will take flexible and appropriate actions to face the changes in the post-epidemic era, implement product, service, and professional empowerment, and cooperate closely with our suppliers to achieve further success in the future."